CNTB logo

CNTB Return On Equity

Annual ROE

-58.89%
+16.09%+21.46%

December 31, 2023


Summary


Performance

CNTB ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTBprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

CNTB ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.5%-
3 y3 years-177.5%-
5 y5 years-204.2%-

CNTB ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+21.5%
5 y5-year-177.5%+21.5%
alltimeall time-177.5%+21.5%

Connect Biopharma Holdings Limited ROE History

DateAnnualQuarterly
Dec 2023
-58.89%(-21.5%)
-
Dec 2022
-74.98%(+0.9%)
-
DateAnnualQuarterly
Dec 2021
-74.29%(-197.7%)
-
Dec 2020
76.03%(+34.5%)
-
Dec 2019
56.53%
-

FAQ

  • What is Connect Biopharma Holdings Limited annual return on equity?
  • What is the all time high annual ROE for Connect Biopharma Holdings Limited?
  • What is Connect Biopharma Holdings Limited annual ROE year-on-year change?

What is Connect Biopharma Holdings Limited annual return on equity?

The current annual ROE of CNTB is -58.89%

What is the all time high annual ROE for Connect Biopharma Holdings Limited?

Connect Biopharma Holdings Limited all-time high annual return on equity is 76.03%

What is Connect Biopharma Holdings Limited annual ROE year-on-year change?

Over the past year, CNTB annual return on equity has changed by +16.09% (+21.46%)